M-Methyl Piperizene Derivative Of Moxifloxacin

Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC
Predrag Djurdjevic a, Andrija Ciric a, Aleksandra Djurdjevic b, Milena Jelikic Stankov
Journal of Pharmaceutical and Biomedical Analysis 50 (2009) 117–126
 
Development and validation of stability indicating UPLC method for the quantitative determination of related substances in moxifloxacin hydrochloride
B. Lakshmi Sushma, G. Madhusudhan a , A. Jayashree b ,P. Srinivasulu a , Y.Koti Reddy
Journal of Pharmacy Research 2015,9(4),211-216

M-Methyl Piperizene Derivative Of Moxifloxacin is chemically 1-Cyclopropyl-6-fluoro-8-methoxy-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. M-Methyl Piperizene Derivative Of Moxifloxacin is supplied with detailed characterization data compliant with regulatory guideline. M-Methyl Piperizene Derivative Of Moxifloxacin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Moxifloxacin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.